Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded at $8.12 at close of the session on Friday, April 26, made an upward move of 3.57% on its previous day’s price.
Looking at the stock we see that its previous close was $7.84 . In terms of its 52-week price range, RXRX has a high of $16.75 and a low of $4.54. The company’s stock has lost about -20.16% over that past 30 days.
Recursion Pharmaceuticals Inc has a market cap of $1.93 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.42, with the EPS growth for the year raised at -$1.72 for 2024 and -$1.86 for next year. These figures represent -8.90% and -8.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $12.65 million, with a low of $10 million and a high of $20.8 million. The median projection represents growth squeezing down to 4.30% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $56.16 million, or 26.00% up from figures reported last year.
On the other hand, looking at the outlook for the RXRX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -2.93% off its SMA20 and -22.49% from its 50-day simple moving average. The RSI (14) is pointing at 41.50 while the volatility over the past week is 5.85% and jumps to 5.35% over the past one month. The beta value is 0.84, while the average true range (ATR) is currently pointing at 0.57.
Coming back to Recursion Pharmaceuticals Inc (NASDAQ:RXRX), we note that the average 3-month trading volume was 6.36 million. Current shares outstanding are 226.26 million.
The insiders hold 31.78% of the company’s shares while institutions hold 75.46%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -17.65% down in year-to-date price movement.
